Keyword: threshold levels

  • New York to Act on New Medication Rules

    New York regulators are ready to consider final revisions to rules specifying allowable testing threshold levels for two dozen medications used to treat Thoroughbreds in advance of races.

  • Booklet on MD Medication Guidelines Released

    A booklet put together by several individuals at the forefront of equine medication reform has been prepared for Maryland, which will enact the Mid-Atlantic Uniform Medication and Drug-Testing Program Jan. 1, 2014.

  • Racing Rules Get Preliminary Approval in NY

    Racing regulators in New York gave preliminary approval to new threshold levels for 24 equine drugs as well as hefty fines for racetracks, lottery agents, and others who let underage people gamble.

  • Ohio Eyes Changes in Drug Policy and Testing

    The Ohio State Racing Commission is moving forward to adopt drug-testing threshold levels as part of national model rules, and also indicated it will switch to post-race TCO2 screening and bring Thoroughbreds into the mix.

  • RCI Board Votes to Lower Bute Threshold

    The Association of Racing Commissioners International board of directors voted Oct. 22 to lower the threshold level for phenylbutazone from five micrograms per milliliter of plasma or serum to two.

  • RMTC Acts to Reduce Potential Impact of Bute

    The Racing Medication and Testing Consortium has lowered the testing threshold level for phenylbutazone, a commonly used non-steroidal anti-inflammatory drug, but has kept the administration time at 24 hours prior to a race.

  • Drug Uniformity Remains Somewhat Elusive

    Though studies have been completed to determine threshold levels for almost 20 therapeutic medications, it doesn't mean the industry will know for certain whether the drugs can impact equine performance.

  • Can Public, Fans Understand Drug Testing?

    The sensitivity of equine drug testing is a big plus for the racing industry, but it also has created confusion. How are the public and media supposed to understand when some industry participants can't make sense of it?

  • Maryland: Study Needed on Steroids

    The Maryland Racing Commission remains committed to regulating anabolic steroids in racehorses, but will delay implementation of a model rule given questions about the rule itself and laboratory testing procedures.

  • Model Rule on Steroid Use Blasted

    The model rule regulating use of anabolic steroids in racehorses is flawed and not based on scientific evidence, and the current state-by-state roll out of the regulations is problematic, horsemen's representatives said Jan. 25.

  • Committee to Look at California Medication Thresholds

    The National Horsemen's Benevolent and Protective Association Medication Committee will review California research that helped develop thresholds for two therapeutic medications during its meeting July 14 in Bloomington, Minn., as part of the National HBPA summer convention.

  • National HBPA Voices Opinions on Medication

    The National Horsemen's Horsemen's Benevolent and Protective Association, given the results of a recent study, has suggested research into medication thresholds and withdrawal times be performed using horses in training.

  • Shock-Wave Regulations, Threshold Levels Sought

    Kentucky officials will consider regulations for use of shock-wave therapy in racehorses and also whether money for equine drug research should be spent on establishing threshold levels and withdrawal times for permitted medications.

  • Morphine Positives Bring Call for Threshold Levels

    Be My Royal, winner of the one the biggest races of the National Hunt season to date, faces disqualification in connection with a rash of positive drug tests for traces of morphine in British and Irish races due to contaminated feed.

  • National HBPA to Issue Revised Medication Proposal

    The National Horsemen's Benevolent and Protective Association is prepared to release a revised proposal for a national policy on drug testing and therapeutic medication. The document deals with Class 1, 2, 3, and 4 medications, as well as prohibited practices.